UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042049
Receipt number R000047887
Scientific Title Effect of the test food containing plant extract on postprandial blood glucose
Date of disclosure of the study information 2020/10/09
Last modified on 2021/03/17 14:29:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of the test food containing plant extract on postprandial blood glucose

Acronym

Effect of the test food containing plant extract on postprandial blood glucose

Scientific Title

Effect of the test food containing plant extract on postprandial blood glucose

Scientific Title:Acronym

Effect of the test food containing plant extract on postprandial blood glucose

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of the test food on postprandial blood glucose

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

AUC of blood glucose levels

Key secondary outcomes

Postprandial blood glucose levels at 30, 60, 90 and 120 minutes after meal, AUC of blood insulin levels, Postprandial blood insulin levels at 30, 60, 90 and 120 minutes after meal


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single intake of the placebo food -> Washout period -> Single intake of the test food 2 -> Washout period -> Single intake of the test food 1

Interventions/Control_2

Single intake of the test food 1 -> Washout period -> Single intake of the placebo food -> Washout period -> Single intake of the test food 2

Interventions/Control_3

Single intake of the test food 2 -> Washout period -> Single intake of the test food 1 -> Washout period -> Single intake of the placebo food

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1)Males and females aged 20 to 64 years
2)Healthy subjects whose screening test results are not greatly out of nomal range
3)Subjects whose fasting blood glucose levels are less than 126 mg/dL, postprandial blood glucose levels are 140 mg/dL or more at 30 or 60 minutes after meal and 199 mg/dL or less at 120 minutes after meal
4)Subjects who agree to participate and can write signature and date in the written informed consent

Key exclusion criteria

1)Subjects who have a history of serious disease or digestive surgery (except for appendectomy)
2)Subjects who are considered as diabetes or have a history of that
3)Subjects who have serious complications or chronic disease
4)Subjects who habitually take medicine or supplements which may affect blood glucose level
5)Subjects who have allergy to the test food or rice
6)Subjects who are pregnant, lactating, or planning to get pregnant
7)Heavy drinker (more than 60g of alcohol per day) or heavy smoker (more than 20 cigarettes per day)
8)Subjects who are planning to participate in other clinical study during the study period
9)Subjects who have restrictions on the test food or meal for religious or other reasons
10)Subjects who are considered as an inappropriate candidate for other reasons by the doctor in charge

Target sample size

33


Research contact person

Name of lead principal investigator

1st name Susumu
Middle name
Last name Ishikawa

Organization

Medical Corporation Shoureikan Sapporo Yushokan Hospital

Division name

Internal Medicine

Zip code

002-8042

Address

2-8-25, 2-jo, Higashibarato, Kita-ku, Sapporo, Hokkaido

TEL

011-772-9211

Email

Ishikawa_seiryo@yahoo.co.jp


Public contact

Name of contact person

1st name Isao
Middle name
Last name Takehara

Organization

Clinical Support Corporation Co., Ltd

Division name

PI-Food Service Division

Zip code

060-0061

Address

8-4-1, Minami 1-jo, Chuo-ku, Sapporo, Hokkaido

TEL

011-223-3130

Homepage URL


Email

takehara@csc-smo.co.jp


Sponsor or person

Institute

Medical Corporation Shoureikan Sapporo Yushokan Hospital

Institute

Department

Personal name



Funding Source

Organization

KOBAYASHI Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Medical Corporation Hokubukai Utsukushigaoka Hospital

Address

61-1, Shinei, Kiyota-ku, Sapporo, Hokkaido

Tel

011-82-0111

Email

matsuda@ughp-cpc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 09 Month 03 Day

Date of IRB

2020 Year 09 Month 10 Day

Anticipated trial start date

2020 Year 10 Month 12 Day

Last follow-up date

2020 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 10 Month 08 Day

Last modified on

2021 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047887


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name